This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Effects of neomycin polymyxin: A Synthesis of Findings from 19 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of neomycin polymyxin: A Synthesis of Findings from 19 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to Dataset
Please check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Major research findings

Several studies have shown that neomycin/polymyxin is an effective topical antibiotic against a variety of infections. 16 found that applying a neomycin/polymyxin solution directly into the surgical wound was effective in reducing the incidence of perioperative infection after implantation of neurostimulation and intrathecal drug delivery devices. 6 found that neomycin/polymyxin sulfate solution bladder wash is effective in preventing catheter-associated urinary tract infection (CAUTI) in intensive care unit patients with traumatic brain injury. 17 investigated the effectiveness of topical antimicrobials against multidrug-resistant organisms (MDROs) and found that some MDROs are susceptible to some topical antibiotics. 15 found that the combination of neomycin and polymyxin B showed synergistic effects against pathogens commonly responsible for otitis externa. 19 demonstrated that triple-antibiotic ointment (TAO) is a safe and effective topical agent for preventing infections in minor skin trauma. 13 introduced a new titanium recording chamber for electrophysiological recordings in behaving monkeys, which utilizes antibiotics such as neomycin, polymyxin, and bacitracin ointment to suppress bacterial proliferation. 1 found that fluconazole does not affect the pharmacokinetics and pharmacodynamics of nateglinide, a new short-acting meglitinide analog antidiabetic drug. 18 evaluated the activity of three over-the-counter topical wound care products against community-associated methicillin-resistant Staphylococcus aureus (MRSA). 2 evaluated the bacterial ocular surface microbiome in ophthalmologically normal dogs before and after topical treatment with neomycin-polymyxin-bacitracin. 3 reported cases of atypical keratopathy in patients prescribed topical postoperative NSAIDs and dexamethasone/neomycin combination therapy after cataract surgery. 7 characterized Ornithobacterium rhinotracheale from commercial layer chickens in eastern Japan. 14 investigated the efficacy and safety of intravesical gentamicin for recurrent urinary tract infection in patients with intermittent bladder catheterization. evaluated the effectiveness of a closed-drainage catheter system with systemic cephaloridine and local irrigation with neomycin-polymyxin in preventing catheter-induced post-prostatectomy infection. 11 evaluated biofilm production by Pseudomonas aeruginosa from canine ears and the impact of biofilm on antimicrobial susceptibility in vitro. 9 found that prenatal antibiotic treatment protected NOD mice from diabetes development through alterations in the gut microbiota, as well as induction of tolerogenic APCs. 12 evaluated the ototoxicity risk from Cortisporin and comparable otic suspensions using distortion-product otoacoustic emission (DPOAE) testing. 10 evaluated the impact of tromethamine edetate disodium dihydrate on antimicrobial susceptibility of Pseudomonas aeruginosa in biofilm in vitro. 4 evaluated the bacterial ocular surface microbiome in clinically normal horses before and after treatment with topical neomycin-polymyxin-bacitracin.

Benefits and Risks

Benefit Summary

Neomycin/polymyxin can be used to treat and prevent various infections. 16 , 6 , 17 , 15 , 19 , 13 , 14 , , 11 , 9 , 4 suggest that neomycin/polymyxin is effective in treating or preventing a variety of infections, including hardware infection after neurosurgical procedures, catheter-associated urinary tract infection, otitis externa, wound infection, and development of diabetes. 2 suggests that neomycin/polymyxin does not affect the bacterial flora on the ocular surface of dogs.

Risk Summary

Neomycin/polymyxin can have a risk of side effects. 8 suggests that neomycin/polymyxin can decrease the levels of collagen and α-tubulin in mouse tympanic membrane fibroblasts, suggesting the potential for ototoxicity. 5 reported punctal stenosis in six dogs following long-term use of topical neomycin-polymyxin B-dexamethasone (NPD). 3 reported cases of atypical keratopathy in patients prescribed topical postoperative NSAIDs and dexamethasone/neomycin combination therapy after cataract surgery. Additionally, there is a risk of allergic reaction to neomycin/polymyxin. 19 reported that the risk of allergic sensitivity to TAO is low, but there is still a risk of allergic reaction.

Comparison Between Studies

Commonalities Between Studies

Many studies indicate that neomycin/polymyxin is effective against a variety of infections. 16 , 6 , 17 , 15 , 19 , 13 , 1 , 18 , 14 , , 11 , 9 show that neomycin/polymyxin is effective in treating or preventing a variety of infections. Studies also indicate that allergic reactions to neomycin/polymyxin are relatively rare. 19 reported that the risk of allergic sensitivity to TAO is low.

Differences Between Studies

The range of infections for which neomycin/polymyxin is considered effective and the potential side effects vary between studies. 8 showed that neomycin/polymyxin may have a detrimental effect on mouse tympanic membrane fibroblasts. 5 showed a risk of punctal stenosis with long-term use. 3 reported corneal side effects in combination with topical NSAIDs after cataract surgery. 7 did not investigate the effectiveness of neomycin/polymyxin against Ornithobacterium rhinotracheale. 2 suggests that neomycin/polymyxin does not affect the bacterial flora on the ocular surface of dogs.

Consistency and Contradictions of the Results

These studies suggest that neomycin/polymyxin is effective against a variety of infections, however, further research is needed to assess the risk of side effects and the effectiveness against specific infections and individuals. 8 , 5 , 3 suggest that neomycin/polymyxin may cause side effects under certain conditions. Further, some studies suggest that neomycin/polymyxin may not be effective for everyone. 17 suggests that some MDROs are less susceptible to neomycin/polymyxin.

Considerations for Application in Real Life

Neomycin/polymyxin is a topical antibiotic that can be effective in treating and preventing various infections, but there are also side effects. 8 , 5 , 3 suggest that neomycin/polymyxin may cause side effects under certain conditions. Therefore, it is important to avoid self-treating with neomycin/polymyxin. Use it according to your doctor's instructions and consult your doctor immediately if you experience any side effects.

Limitations of Current Research

These studies provide valuable information about the efficacy and safety of neomycin/polymyxin, but there are some limitations. For example, many studies are small and have a limited number of subjects, which may make the results less generalizable. Furthermore, these studies do not provide specific guidance on how to apply neomycin/polymyxin to different infections.

Future Research Directions

Further research is needed to further investigate the effectiveness and safety of neomycin/polymyxin. In particular, research is needed to provide specific guidance on how to apply neomycin/polymyxin to different infections. Studies are also needed to investigate the development of resistance to neomycin/polymyxin.

Conclusion

Neomycin/polymyxin is a topical antibiotic that can be effective against a variety of infections, but there is also a risk of side effects. 8 , 5 , 3 suggest that neomycin/polymyxin may cause side effects under certain conditions. Self-treating with neomycin/polymyxin should be avoided. Use it according to your doctor's instructions and consult your doctor immediately if you experience any side effects. Further research is needed to further investigate the effectiveness and safety of neomycin/polymyxin.


Literature analysis of 19 papers
Positive Content
14
Neutral Content
1
Negative Content
4
Article Type
1
0
1
2
18

Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


Language : English


This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.